News Conference News ESC 2016 Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results Shelley Wood August 28, 2016
News Conference News ESC 2016 New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study Shelley Wood August 27, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year Michael H. Wilson June 28, 2016
News Industry News Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure June 27, 2016
News Conference News ACC 2016 CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results Shelley Wood April 08, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Daily News Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure Michael O'Riordan January 19, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Industry News BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology December 13, 2015
News Industry News BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode December 08, 2015
News Industry News Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure October 22, 2015
News Conference News TCT 2015 TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year Nicole Lou October 13, 2015
News Conference News TCT 2015 Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored October 13, 2015
News Industry News Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months September 28, 2015
News Conference News ESC 2015 TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics Yael L. Maxwell August 31, 2015
News Industry News Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority June 22, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015